[1]
|
NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND VARIANT VAL-415.
PubMed=7722300 [NCBI, ExPASy, EBI, Israel, Japan]
Ruegg C.L.,
Rivas A.,
Madani N.D.,
Zeitung J.,
Laus R.,
Engleman E.G.;
"V7, a novel leukocyte surface protein that participates in T cell activation. II. Molecular cloning and characterization of the V7 gene.";
J. Immunol. 154:4434-4443(1995).
|
[2]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
DOI=10.1038/nature04727; PubMed=16710414 [NCBI, ExPASy, EBI, Israel, Japan]
Gregory S.G.,
Barlow K.F.,
McLay K.E.,
Kaul R.,
Swarbreck D.,
Dunham A.,
Scott C.E.,
Howe K.L.,
Woodfine K.,
Spencer C.C.A.,
Jones M.C.,
Gillson C.,
Searle S.,
Zhou Y.,
Kokocinski F.,
McDonald L.,
Evans R.,
Phillips K.,
Atkinson A., ![]()
Cooper R.,
Jones C.,
Hall R.E.,
Andrews T.D.,
Lloyd C.,
Ainscough R.,
Almeida J.P.,
Ambrose K.D.,
Anderson F.,
Andrew R.W.,
Ashwell R.I.S.,
Aubin K.,
Babbage A.K.,
Bagguley C.L.,
Bailey J.,
Beasley H.,
Bethel G.,
Bird C.P.,
Bray-Allen S.,
Brown J.Y.,
Brown A.J.,
Buckley D.,
Burton J.,
Bye J.,
Carder C.,
Chapman J.C.,
Clark S.Y.,
Clarke G.,
Clee C.,
Cobley V.,
Collier R.E.,
Corby N.,
Coville G.J.,
Davies J.,
Deadman R.,
Dunn M.,
Earthrowl M.,
Ellington A.G.,
Errington H.,
Frankish A.,
Frankland J.,
French L.,
Garner P.,
Garnett J.,
Gay L.,
Ghori M.R.J.,
Gibson R.,
Gilby L.M.,
Gillett W.,
Glithero R.J.,
Grafham D.V.,
Griffiths C.,
Griffiths-Jones S.,
Grocock R.,
Hammond S.,
Harrison E.S.I.,
Hart E.,
Haugen E.,
Heath P.D.,
Holmes S.,
Holt K.,
Howden P.J.,
Hunt A.R.,
Hunt S.E.,
Hunter G.,
Isherwood J.,
James R.,
Johnson C.,
Johnson D.,
Joy A.,
Kay M.,
Kershaw J.K.,
Kibukawa M.,
Kimberley A.M.,
King A.,
Knights A.J.,
Lad H.,
Laird G.,
Lawlor S.,
Leongamornlert D.A.,
Lloyd D.M.,
Loveland J.,
Lovell J.,
Lush M.J.,
Lyne R.,
Martin S.,
Mashreghi-Mohammadi M.,
Matthews L.,
Matthews N.S.W.,
McLaren S.,
Milne S.,
Mistry S.,
Moore M.J.F.,
Nickerson T.,
O'Dell C.N.,
Oliver K.,
Palmeiri A.,
Palmer S.A.,
Parker A.,
Patel D.,
Pearce A.V.,
Peck A.I.,
Pelan S.,
Phelps K.,
Phillimore B.J.,
Plumb R.,
Rajan J.,
Raymond C.,
Rouse G.,
Saenphimmachak C.,
Sehra H.K.,
Sheridan E.,
Shownkeen R.,
Sims S.,
Skuce C.D.,
Smith M.,
Steward C.,
Subramanian S.,
Sycamore N.,
Tracey A.,
Tromans A.,
Van Helmond Z.,
Wall M.,
Wallis J.M.,
White S.,
Whitehead S.L.,
Wilkinson J.E.,
Willey D.L.,
Williams H.,
Wilming L.,
Wray P.W.,
Wu Z.,
Coulson A.,
Vaudin M.,
Sulston J.E.,
Durbin R.M.,
Hubbard T.,
Wooster R.,
Dunham I.,
Carter N.P.,
McVean G.,
Ross M.T.,
Harrow J.,
Olson M.V.,
Beck S.,
Rogers J.,
Bentley D.R.;
"The DNA sequence and biological annotation of human chromosome 1.";
Nature 441:315-321(2006).
|
[3]
|
FUNCTION, GLYCOSYLATION, AND TISSUE SPECIFICITY.
PubMed=7722299 [NCBI, ExPASy, EBI, Israel, Japan]
Rivas A.,
Ruegg C.L.,
Zeitung J.,
Laus R.,
Warnke R.,
Benike C.,
Engleman E.G.;
"V7, a novel leukocyte surface protein that participates in T cell activation. I. Tissue distribution and functional studies.";
J. Immunol. 154:4423-4433(1995).
|
[4]
|
FUNCTION.
PubMed=9233604 [NCBI, ExPASy, EBI, Israel, Japan]
Soares L.R.B.,
Rivas A.,
Tsavaler L.,
Engleman E.G.;
"Ligation of the V7 molecule on T cells blocks anergy induction through a CD28-independent mechanism.";
J. Immunol. 159:1115-1124(1997).
|
[5]
|
TISSUE SPECIFICITY, AND FUNCTION.
DOI=10.1111/j.1399-0039.1997.tb02898.x; PubMed=9389317 [NCBI, ExPASy, EBI, Israel, Japan]
Bagot M.,
Martinel I.,
Charue D.,
Weill F.,
Boulland M.-L.,
Wechsler J.,
Freeman G.J.,
Bensussan A.,
Boumsell L.;
"CD101 is expressed by skin dendritic cells. Role in T-lymphocyte activation.";
Tissue Antigens 50:439-448(1997).
|
[6]
|
FUNCTION.
PubMed=9647226 [NCBI, ExPASy, EBI, Israel, Japan]
Soares L.R.B.,
Tsavaler L.,
Rivas A.,
Engleman E.G.;
"V7 (CD101) ligation inhibits TCR/CD3-induced IL-2 production by blocking Ca2+ flux and nuclear factor of activated T cell nuclear translocation.";
J. Immunol. 161:209-217(1998).
|
[7]
|
FUNCTION.
DOI=10.1002/1521-4141(200011)30:11<3132::AID-IMMU3132>3.0.CO;2-E; PubMed=11093127 [NCBI, ExPASy, EBI, Israel, Japan]
Bouloc A.,
Bagot M.,
Delaire S.,
Bensussan A.,
Boumsell L.;
"Triggering CD101 molecule on human cutaneous dendritic cells inhibits T cell proliferation via IL-10 production.";
Eur. J. Immunol. 30:3132-3139(2000).
|
[8]
|
TISSUE SPECIFICITY.
DOI=10.1046/j.1365-2559.2000.00827.x; PubMed=10692025 [NCBI, ExPASy, EBI, Israel, Japan]
Bouloc A.,
Boulland M.-L.,
Geissmann F.,
Fraitag S.,
Andry P.,
Teillac D.,
Bensussan A.,
Revuz J.,
Boumsell L.,
Wechsler J.,
Bagot M.;
"CD101 expression by Langerhans cell histiocytosis cells.";
Histopathology 36:229-232(2000).
|
[9]
|
DOMAIN EWI MOTIF.
DOI=10.1074/jbc.M107338200; PubMed=11504738 [NCBI, ExPASy, EBI, Israel, Japan]
Stipp C.S.,
Kolesnikova T.V.,
Hemler M.E.;
"EWI-2 is a major CD9 and CD81 partner and member of a novel Ig protein subfamily.";
J. Biol. Chem. 276:40545-40554(2001).
|
[10]
|
FUNCTION, AND TISSUE SPECIFICITY.
DOI=10.1111/j.0022-202X.2005.23617.x; PubMed=15737213 [NCBI, ExPASy, EBI, Israel, Japan]
Meyer N.,
Petrella T.,
Poszepczynska-Guigne E.,
Boumsell L.,
Wechsler J.,
Bensussan A.,
Bagot M.;
"CD4+ CD56+ blastic tumor cells express CD101 molecules.";
J. Invest. Dermatol. 124:668-669(2005).
|
|
ExPASy Home page
SIB Switzerland
